PROMETIC REPORTS SUCCESSFUL PBI-4050 PRE-IND MEETING WITH THE US FDA FOR IDIOPATHIC PULMONARY FIBROSIS (“IPF”)

October 1, 2015
Posted by: Prometic Prometic
Posted In: Press Releases 2015
X